十字架 发表于 2025-3-25 07:03:44

Submitted on: 28 April 2017.
Revised on: 27 July 2017.
Accepted on: 16 August 2017.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

不感兴趣 发表于 2025-3-25 10:11:21

Submitted on: 23 March 2010.
Revised on: 22 April 2010.
Accepted on: 16 June 2010.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

Confound 发表于 2025-3-25 15:10:54

http://reply.papertrans.cn/1/94/9342/9342-23.png

机警 发表于 2025-3-25 19:48:35

Submitted on: 02 September 2021.
Revised on: 17 November 2021.
Accepted on: 06 December 2021.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

archaeology 发表于 2025-3-25 20:20:15

Submitted on: 01 July 2022.
Revised on: 07 September 2022.
Accepted on: 14 October 2022.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

Morsel 发表于 2025-3-26 03:04:40

Submitted on: 26 August 2014.
Revised on: 14 December 2014.
Accepted on: 01 January 2015.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

Goblet-Cells 发表于 2025-3-26 07:42:34

Submitted on: 04 September 2016.
Revised on: 29 November 2016.
Accepted on: 07 January 2017.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

oncologist 发表于 2025-3-26 09:09:19

http://reply.papertrans.cn/1/94/9342/9342-28.png

遗留之物 发表于 2025-3-26 16:33:02

http://reply.papertrans.cn/1/94/9342/9342-29.png

Aggrandize 发表于 2025-3-26 19:30:16

Submitted on: 12 April 2016.
Revised on: 22 July 2016.
Accepted on: 24 August 2016.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY
页: 1 2 [3] 4
查看完整版本: SCIE期刊EUROPEAN NEUROPSYCHOPHARMACOLOGY 2024/2025影响因子:6.196 (EUR NEUROPSYCHOPHARM) (0924-977X). (CLINICAL NEUROLOGY)(临床神